EP3463469
COMBINATION OF LEDIPASVIR AND SOFOSBUVIR FOR USE IN THE TREATMENT OF HEPATITIS B VIRUS INFECTIONS IN HUMANS
:
EP einkaleyfi: Þýðing ekki lögð inn:
11.5.2017:
13.12.2023:
17725086.7
:
10.5.2037
:
COMBINATION OF LEDIPASVIR AND SOFOSBUVIR FOR USE IN THE TREATMENT OF HEPATITIS B VIRUS INFECTIONS IN HUMANS
11.5.2017
13.12.2023
:
Gilead Sciences, Inc.:
333 Lakeside Drive, Foster City, CA 94404, US
:
GAGGAR, Anuj:
Foster City, CA 94404, US
:
SUBRAMANIAN, G., Mani:
Foster City, CA 94404, US
:
201662342787 P:
27.5.2016:
US
:
US2017032282:
11.5.2017
:
A61K 45/06, A61K 31/454, A61K 31/498, A61K 31/675, A61K 31/7072, A61P 31/14